Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Cindy Kristina Enggi, Mega Tri Satria, Nirmayanti Nirmayanti, Jesscia Theodor Usman, Julika Fajrika Nur, Rangga Meidianto Asri, Nana Juniarti Natsir Djide & Andi Dian Permana. (2023) Improved transdermal delivery of valsartan using combinatorial approach of polymeric transdermal hydrogels and solid microneedles: an ex vivo proof of concept investigation. Journal of Biomaterials Science, Polymer Edition 34:3, pages 334-350.
Read now
Read now
Ahmad Shakeel, Francesca R. Lupi, Domenico Gabriele, Noemi Baldino & Bruno De Cindio. (2018) Bigels: A unique class of materials for drug delivery applications. Soft Materials 16:2, pages 77-93.
Read now
Read now
S.
S. Sagiri, B. Behera, R.
R. Rafanan, C. Bhattacharya, K. Pal, I. Banerjee & D. Rousseau. (2014) Organogels as Matrices for Controlled Drug Delivery: A Review on the Current State. Soft Materials 12:1, pages 47-72.
Read now
Read now
Umberto Leone Roberti Maggiore, Stefano Salvatore, Franco Alessandri, Valentino Remorgida, Massimo Origoni, Massimo Candiani, Pier Luigi Venturini & Simone Ferrero. (2012) Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females. Expert Opinion on Drug Metabolism & Toxicology 8:11, pages 1387-1408.
Read now
Read now
Alex Gomelsky & Roger R Dmochowski. (2012) Oxybutynin gel for the treatment of overactive bladder. Expert Opinion on Pharmacotherapy 13:9, pages 1337-1343.
Read now
Read now
Marcus J Drake. (2008) Emerging drugs for treatment of overactive bladder and detrusor overactivity. Expert Opinion on Emerging Drugs 13:3, pages 431-446.
Read now
Read now
Amal H. El-Kamel, Iman M. Al-Fagih & Ibrahim A. Alsarra. (2007) Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization. Journal of Microencapsulation 24:5, pages 457-475.
Read now
Read now
G Willy Davila. (2006) Transdermal oxybutynin in the treatment of overactive bladder. Clinical Interventions in Aging 1:2, pages 99-105.
Read now
Read now
Articles from other publishers (20)
Aneta Ostróżka-Cieślik, Sławomir Wilczyński & Barbara Dolińska. (2023) Hydrogel Formulations for Topical Insulin Application: Preparation, Characterization and In Vitro Permeation across the Strat-M® Membrane. Polymers 15:17, pages 3639.
Crossref
Crossref
Braja Bihari Panda, Bala Krishna Kala, Ankita Parmanik, Dattatreya Kar & Anindya Bose. (2023) Formulation, Development and Evaluation of Sildenafil Citrate Oral Jelly. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 5, pages 122-126.
Crossref
Crossref
Nirmayanti Nirmayanti, Alhidayah Alhidayah, Jessica Theodor Usman, Julika Fajrika Nur, Muh. Nur Amir & Andi Dian Permana. (2022) Combinatorial Approach of Thermosensitive Hydrogels and Solid Microneedles to Improve Transdermal Delivery of Valsartan: an In Vivo Proof of Concept Study. AAPS PharmSciTech 24:1.
Crossref
Crossref
Aneta Ostróżka-Cieślik. (2022) The Potential of Pharmaceutical Hydrogels in the Formulation of Topical Administration Hormone Drugs. Polymers 14:16, pages 3307.
Crossref
Crossref
Mark S. Newman, Desmond A. Curran, Bryan P. Mayfield, Doreen Saltiel & Frank Z. Stanczyk. (2022) Assessment of estrogen exposure from transdermal estradiol gel therapy with a dried urine assay. Steroids 184, pages 109038.
Crossref
Crossref
Larissa Carine Pünnel & Dominique Jasmin Lunter. (2021) Film-Forming Systems for Dermal Drug Delivery. Pharmaceutics 13:7, pages 932.
Crossref
Crossref
Mahgol Tajbakhsh, Majid Saeedi, Jafar Akbari, Katayoun Morteza-Semnani, Ali Nokhodchi & Akbar Hedayatizadeh-Omran. (2020) An investigation on parameters affecting the optimization of testosterone enanthate loaded solid nanoparticles for enhanced transdermal delivery. Colloids and Surfaces A: Physicochemical and Engineering Aspects 589, pages 124437.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2019) Testosterone 2% gel (Testavan®, Testarzon®) in adult male hypogonadism: a profile of its use. Drugs & Therapy Perspectives 35:5, pages 209-218.
Crossref
Crossref
Qianwen Wang, Zhong Zuo, Cheuk Kit Chucky Cheung & Sharon Shui Yee Leung. (2019) Updates on thermosensitive hydrogel for nasal, ocular and cutaneous delivery. International Journal of Pharmaceutics 559, pages 86-101.
Crossref
Crossref
Joshua A. Cohn, Elizabeth T. Brown, W. Stuart Reynolds, Melissa R. Kaufman, Douglas F. Milam & Roger R. Dmochowski. (2016) An update on the use of transdermal oxybutynin in the management of overactive bladder disorder. Therapeutic Advances in Urology 8:2, pages 83-90.
Crossref
Crossref
Ju-Young Kim, Joon-Ho Jun, Sang-Joon Kim, Kyu-Mok Hwang, Sung Rak Choi, Sang Duk Han, Mi-Won Son & Eun-Seok Park. (2014) Wound healing efficacy of a chitosan-based film-forming gel containing tyrothricin in various rat wound models. Archives of Pharmacal Research 38:2, pages 229-238.
Crossref
Crossref
Håkan Olsson, Rikard Sandström, Anders Neijber, Dario Carrara & Lars Grundemar. (2014) Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men. Clinical Pharmacology in Drug Development 3:5, pages 358-364.
Crossref
Crossref
Christina Wang, Niloufar Ilani, Stefan Arver, Robert I. McLachlan, Tina Soulis & Adam Watkinson. (2011) Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men. Clinical Endocrinology 75:6, pages 836-843.
Crossref
Crossref
Ruiwei Guo, Xiaoyan Du, Rui Zhang, Liandong Deng, Anjie Dong & Jianhua Zhang. (2011) Bioadhesive film formed from a novel organic–inorganic hybrid gel for transdermal drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics 79:3, pages 574-583.
Crossref
Crossref
. (2010) Topical Oxybutynin (Gelnique) for Overactive Bladder. Obstetrics & Gynecology 115:5, pages 1078-1079.
Crossref
Crossref
G. Popken. (2010) TestosteronsubstitutionTestosterone replacement. Der Urologe 49:1, pages 37-42.
Crossref
Crossref
Biancamaria Baroli. (2010) Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality?. Journal of Pharmaceutical Sciences 99:1, pages 21-50.
Crossref
Crossref
U. Paasch, H.-J. Glander & J.-U. Stolzenburg. (2009) Andrologische TestosteronersatztherapieAndrological testosterone replacement therapy. Der Urologe 48:1, pages 79-87.
Crossref
Crossref
Dolores D. Mruk, Bruno Silvestrini & C. Yan Cheng. (2008) Anchoring Junctions As Drug Targets: Role in Contraceptive Development. Pharmacological Reviews 60:2, pages 146-180.
Crossref
Crossref
M. de Sèze, A. Ruffion & E. Chartier-Kastler. (2007) Chapitre C-l A - Traitement pharmacologique de l’hyperactivité détrusorienne neurologique : per os, en patch, en instillation endo-vésicale. Progrès en Urologie 17:3, pages 559-563.
Crossref
Crossref